HARTA 5168 QUARTERLY REPORT 31 DEC 2018
Quarterly Report Review:
收入与去年同期相比增加19.9%主要是对手套的需求强劲。
该集团的第五号工厂的生产线共有12条并已营运6条了。
该集团的第六号工厂的设备将会在下半年开始到来。
该集团预计第五号和第六号工厂的年产量为47亿只手套。
该集团的第七号工厂将会专注在特别的产品，预计年产量为26亿只手套。
该集团获得其它10个国家的抗菌手套订单，还获得美国联邦药品管理局（FDA）为安全所提供强有力的第三方证明以及证明产品的有效性。
Reference Price:
12.02.2019
Price: RM 5.45
Rolling EPS: RM 0.1452
PE: 37.53
NTA: RM 0.66
Price/NTA: 8.26
PE*Price/NTA: 309.91
Undervalued: RM 1.11
Fair Value: RM 1.47
Overvalued: RM 2.21
Disclaimer:
The information contained in this research is based on data obtained from sources believed to be reliable. However, the data and/or sources have not been independently verified and as such, no representation, express or implied, is made as to the accuracy, adequacy, completeness or reliability of the info or opinions in the research.
Accordingly, neither 以牛攻熊 nor any of its related companies and associates nor person connected to it accept any liability whatsoever for any direct, indirect or consequential losses (including loss of profits) or damages that may arise from the use or reliance on the info or opinions in this publication. Any information, opinions or recommendations contained herein are subject to change at any time without prior notice. 以牛攻熊 has no obligation to update its opinion or the information in this research.
Investors are advised to make their own independent evaluation of the info contained in this research and seek independent financial, legal or other advice regarding the appropriateness of investing in any securities or the investment strategies discussed or recommended in this research. Nothing in this research constitutes investment, legal, accounting or tax advice or a representation that any investment or strategy is suitable or appropriate to your individual circumstances or otherwise represent a personal recommendation to you.
This research is being supplied to you on a strictly confidential basis solely for your information and is made strictly on the basis that it will remain confidential. All materials presented in this research, unless specifically indicated otherwise, is under copyright to 以牛攻熊. This research and its contents may not be reproduced, stored in a retrieval system, redistributed, transmitted or passed on, directly or indirectly, to any person or published in whole or in part, or altered in any way, for any purpose.
This research may provide the addresses of, or contain hyperlinks to, websites. 以牛攻熊 takes no responsibility for the content contained therein. Such addresses or hyperlinks (including addresses or hyperlinks to 以牛攻熊 own site material) are provided solely for your convenience. The information and the content of the linked site do not in any way form part of this research. Accessing such website or following such link through the research or 以牛攻熊 site shall be at your own risk.
收入与去年同期相比增加19.9%主要是对手套的需求强劲。
该集团的第五号工厂的生产线共有12条并已营运6条了。
该集团的第六号工厂的设备将会在下半年开始到来。
该集团预计第五号和第六号工厂的年产量为47亿只手套。
该集团的第七号工厂将会专注在特别的产品，预计年产量为26亿只手套。
该集团获得其它10个国家的抗菌手套订单，还获得美国联邦药品管理局（FDA）为安全所提供强有力的第三方证明以及证明产品的有效性。
Reference Price:
12.02.2019
Price: RM 5.45
Rolling EPS: RM 0.1452
PE: 37.53
NTA: RM 0.66
Price/NTA: 8.26
PE*Price/NTA: 309.91
Undervalued: RM 1.11
Fair Value: RM 1.47
Overvalued: RM 2.21
Disclaimer:
The information contained in this research is based on data obtained from sources believed to be reliable. However, the data and/or sources have not been independently verified and as such, no representation, express or implied, is made as to the accuracy, adequacy, completeness or reliability of the info or opinions in the research.
Accordingly, neither 以牛攻熊 nor any of its related companies and associates nor person connected to it accept any liability whatsoever for any direct, indirect or consequential losses (including loss of profits) or damages that may arise from the use or reliance on the info or opinions in this publication. Any information, opinions or recommendations contained herein are subject to change at any time without prior notice. 以牛攻熊 has no obligation to update its opinion or the information in this research.
Investors are advised to make their own independent evaluation of the info contained in this research and seek independent financial, legal or other advice regarding the appropriateness of investing in any securities or the investment strategies discussed or recommended in this research. Nothing in this research constitutes investment, legal, accounting or tax advice or a representation that any investment or strategy is suitable or appropriate to your individual circumstances or otherwise represent a personal recommendation to you.
This research is being supplied to you on a strictly confidential basis solely for your information and is made strictly on the basis that it will remain confidential. All materials presented in this research, unless specifically indicated otherwise, is under copyright to 以牛攻熊. This research and its contents may not be reproduced, stored in a retrieval system, redistributed, transmitted or passed on, directly or indirectly, to any person or published in whole or in part, or altered in any way, for any purpose.
This research may provide the addresses of, or contain hyperlinks to, websites. 以牛攻熊 takes no responsibility for the content contained therein. Such addresses or hyperlinks (including addresses or hyperlinks to 以牛攻熊 own site material) are provided solely for your convenience. The information and the content of the linked site do not in any way form part of this research. Accessing such website or following such link through the research or 以牛攻熊 site shall be at your own risk.
Comments
Post a Comment